|
US7252829B1
(en)
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US20020168374A1
(en)
*
|
1992-08-07 |
2002-11-14 |
Ralph T. Kubo |
Hla binding peptides and their uses
|
|
US20040110283A1
(en)
*
|
1997-02-27 |
2004-06-10 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products
|
|
US20050170503A1
(en)
*
|
1997-02-27 |
2005-08-04 |
University Of Pittsburgh |
In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
|
|
US7282198B2
(en)
*
|
1997-03-19 |
2007-10-16 |
The University Of Arkansas For Medical Sciences |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
|
|
WO1999024554A2
(en)
|
1997-11-12 |
1999-05-20 |
University Of Pittsburgh |
Isolation, characterization, and identification of dendritic like cells and methods of using same
|
|
AU3305699A
(en)
*
|
1998-02-26 |
1999-09-15 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
AU3102599A
(en)
*
|
1998-03-20 |
1999-10-11 |
Genzyme Corporation |
Compositions and methods for the frozen storage of dendritic cells
|
|
US7402307B2
(en)
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
EP1068296B1
(en)
|
1998-03-31 |
2011-08-10 |
Geron Corporation |
Compositions for eliciting an immune response to a telomerase antigen
|
|
EP1078060B1
(en)
*
|
1998-05-11 |
2007-01-10 |
E.P. Prof. Dr. Rieber |
Antibodies to dendritic cells and human dendritic cell populations and uses thereof
|
|
US7351546B2
(en)
*
|
1998-09-22 |
2008-04-01 |
Becton, Dickinson And Company |
Flow cytometric, whole blood dendritic cell immune function assay
|
|
US6495333B1
(en)
|
1998-09-22 |
2002-12-17 |
Becton Dickinson And Company |
Flow cytometric, whole blood dendritic cell immune function assay
|
|
US6387888B1
(en)
|
1998-09-30 |
2002-05-14 |
American Foundation For Biological Research, Inc. |
Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
|
|
CA2345277C
(en)
|
1998-10-20 |
2011-05-24 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US6787154B2
(en)
*
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
GB9827103D0
(en)
*
|
1998-12-10 |
1999-02-03 |
Onyvax Ltd |
New cancer treatments
|
|
GB9827104D0
(en)
*
|
1998-12-10 |
1999-02-03 |
Onyvax Ltd |
New cancer treatments
|
|
CA2367692A1
(en)
*
|
1999-03-15 |
2000-09-21 |
Introgen Therapeutics, Inc. |
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
|
|
DE60044125D1
(de)
|
1999-04-14 |
2010-05-20 |
Novartis Vaccines & Diagnostic |
Zusammensetzungen und verfahren zur auslösung einer immunantwort auf basis alphavirus-vektoren-systeme
|
|
US7713739B1
(en)
*
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015205B1
(en)
|
1999-10-18 |
2006-03-21 |
St. Vincent's Hospital And Medical Center Of New York |
Melanoma vaccine and methods of making and using same
|
|
KR100363587B1
(ko)
*
|
1999-11-12 |
2002-12-06 |
이시우 |
대식세포와 종양세포의 융합에 의한 항종양 세포성 치료제
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
CN1454215B
(zh)
*
|
1999-11-15 |
2013-01-02 |
米勒腾尼生物技术有限公司 |
树突状细胞特异的抗原结合片段、组合物及其使用方法、被其识别的抗原及由其获得的细胞
|
|
AU1811801A
(en)
*
|
1999-12-03 |
2001-06-12 |
Dendreon Corporation |
Cryopreservation of antigen-loaded dendritic cells and their precursors in serum-free media
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US20030027246A1
(en)
*
|
2000-03-31 |
2003-02-06 |
Artur Pedyczak |
Immunogenic peptides derived from prostate-specific membrane antigen (PSMA) and uses thereof
|
|
CA2408547A1
(en)
*
|
2000-05-11 |
2001-11-15 |
Altarex Corp. |
Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
|
|
US20030175247A1
(en)
*
|
2000-05-12 |
2003-09-18 |
Michael Salgaller |
Method to increase class I presentation of exogenous antigens by human dendritic cells
|
|
DE10041515A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Gerold Schuler |
Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
|
|
CA2460014A1
(en)
*
|
2000-09-21 |
2002-03-28 |
The Regents Of The University Of California |
Spas-1 cancer antigen
|
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
|
AU2002232560A1
(en)
|
2000-10-27 |
2002-05-06 |
Immuno-Rx, Inc |
Vaccine immunotherapy for immune suppressed patients
|
|
US20070025958A1
(en)
*
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
WO2003008537A2
(en)
*
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
US20030082806A1
(en)
*
|
2001-04-27 |
2003-05-01 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated T cells
|
|
CA2459713C
(en)
|
2001-09-06 |
2015-08-18 |
Northwest Biotherapeutics, Inc. |
Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
|
|
WO2003033520A2
(en)
*
|
2001-09-24 |
2003-04-24 |
University Of Pittburgh Of The Commonwealth System Of Higher Education |
Anticancer vaccine and diganostic methods and reagents
|
|
US20050215472A1
(en)
*
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
JP5355839B2
(ja)
*
|
2001-10-23 |
2013-11-27 |
ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． |
Ｐｓｍａ抗体およびタンパク質マルチマー
|
|
AU2002349543A1
(en)
*
|
2001-12-10 |
2003-06-23 |
Kyogo Itoh |
Tumor antigens
|
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
SI1509244T1
(sl)
*
|
2002-06-06 |
2011-11-30 |
Immunicum An |
Nov postopek in spojina za izdelavo celične alogenične vakcine
|
|
CN1713951B
(zh)
|
2002-06-19 |
2010-05-26 |
西北生物治疗药物公司 |
切向流过滤设备和白细胞富集方法
|
|
US20040022813A1
(en)
*
|
2002-08-05 |
2004-02-05 |
Jean-Claude Bystryn |
Shed antigen vaccine with dendritic cells adjuvant
|
|
JP2004196770A
(ja)
*
|
2002-10-24 |
2004-07-15 |
Effector Cell Institute Inc |
樹状細胞前駆体の血中レベル上昇剤
|
|
KR100522526B1
(ko)
*
|
2002-11-28 |
2005-10-19 |
주식회사 바이넥스 |
면역 치료용 수지상 세포의 제조방법
|
|
CN102600461B
(zh)
*
|
2002-12-06 |
2017-07-14 |
西北生物治疗药物公司 |
给予体外部分成熟的树突细胞治疗肿瘤
|
|
US20040202663A1
(en)
*
|
2003-01-28 |
2004-10-14 |
Shanghai Sunway Biotech Co., Ltd. |
Therapy for primary and metastatic cancers
|
|
WO2004075855A2
(en)
*
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
RU2364625C2
(ru)
|
2003-02-27 |
2009-08-20 |
Норсуэст Байотерапьютикс, Инк. |
Генерирование дендритных клеток из моноцитарных предшественников дендритных клеток с помощью gm-csf в отсутствие дополнительных цитокинов
|
|
EP1670513B1
(en)
*
|
2003-10-06 |
2013-01-23 |
Cedars-Sinai Medical Center |
Cox-2 inhibitors and dendritic cells for use in the treatment of cancer.
|
|
JP5015601B2
(ja)
*
|
2003-10-21 |
2012-08-29 |
セダーズ−シナイ メディカル センター |
中枢神経系の癌を含む癌の処置のための系および方法
|
|
DE602005022728D1
(de)
*
|
2004-08-19 |
2010-09-16 |
Univ Cardiff |
Präparation antigenpräsentierender menschlicher gamma delta t-zellen und verwendung in der immuntherapie
|
|
CN100591761C
(zh)
*
|
2004-08-19 |
2010-02-24 |
加的夫大学学院咨询有限公司 |
呈递抗原的人γδT细胞的制备和在免疫治疗中的用途
|
|
WO2006023598A2
(en)
*
|
2004-08-19 |
2006-03-02 |
University Of Maryland, Baltimore |
Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer
|
|
WO2007044033A2
(en)
*
|
2004-12-07 |
2007-04-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
|
|
US8420078B2
(en)
*
|
2005-03-10 |
2013-04-16 |
Yeda Research And Development Co. Ltd. |
Methods and immunogenic cell preparations for treating antigen-associated diseases
|
|
CA2504279A1
(en)
*
|
2005-04-15 |
2006-10-15 |
University Of Saskatchewan |
Materials and method of modulating the immune response using t helper-antigen presenting cells
|
|
EP1888105A2
(en)
*
|
2005-05-12 |
2008-02-20 |
Introgen Therapeutics, Inc. |
P53 vaccines for the treatment of cancers
|
|
SG162817A1
(en)
|
2005-06-17 |
2010-07-29 |
Mannkind Corp |
Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
|
|
US8338173B2
(en)
*
|
2005-08-11 |
2012-12-25 |
University College Cardiff Consultants Limited |
Preparation of antigen-presenting human γδ T cells and use in immunotherapy
|
|
KR20220113543A
(ko)
|
2005-12-08 |
2022-08-12 |
노쓰웨스트 바이오써라퓨틱스, 인크. |
미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한 조성물 및 방법
|
|
WO2007137300A2
(en)
|
2006-05-23 |
2007-11-29 |
Bellicum Pharmaceuticals, Inc. |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
|
CA2700573C
(en)
|
2006-09-26 |
2016-11-22 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
|
CA2700436C
(en)
|
2006-09-28 |
2017-04-18 |
John S. Yu |
Cancer vaccines and vaccination methods
|
|
US8097242B2
(en)
*
|
2006-10-05 |
2012-01-17 |
The Board Of Trustees Of The University Of Arkansas |
Target CA125 peptides for cancer immunotherapy
|
|
JP5563472B2
(ja)
|
2007-11-28 |
2014-07-30 |
アイ アール エックス セーラピューティクス， インコーポレイテッド |
免疫学的効果を増大させる方法
|
|
US20110189093A1
(en)
*
|
2008-04-14 |
2011-08-04 |
Proscan Rx Pharma |
Prostate specific membrane antigen antibodies and antigen binding fragments
|
|
US8748170B2
(en)
|
2008-07-25 |
2014-06-10 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Polypeptides derived from cyclin B1 and uses thereof
|
|
PL2328923T3
(pl)
|
2008-09-02 |
2016-06-30 |
Cedars Sinai Medical Center |
Epitopy CD133
|
|
EP2326350B1
(en)
|
2008-09-08 |
2013-09-04 |
Psma Development Company, L.L.C. |
Compounds for killing psma-expressing, taxane-resistant cancer cells
|
|
DK2352756T3
(da)
|
2008-11-24 |
2012-12-03 |
Helmholtz Zentrum Muenchen |
Højaffin T-cellereceptor og anvendelse af denne
|
|
EP2427485B1
(en)
*
|
2009-05-07 |
2016-12-07 |
ImmunoCellular Therapeutics, Ltd. |
Cd133 epitopes
|
|
CA3017298C
(en)
|
2009-05-15 |
2021-09-28 |
Irx Therapeutics, Inc. |
Compositions comprising primary cell-derived biologics for enhancing immune responses in patients
|
|
ES2667476T3
(es)
|
2009-12-08 |
2018-05-11 |
Irx Therapeutics, Inc. |
Método para invertir la supresión inmunitaria de células de Langerhans
|
|
US20110251128A1
(en)
*
|
2010-02-26 |
2011-10-13 |
The Board Of Regents Of The University Of Texas System |
THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
|
|
US9629357B2
(en)
*
|
2013-02-01 |
2017-04-25 |
Primegen Biotech Llc |
Cryopreservation of cells and tissue for clinical application
|
|
ES2662333T3
(es)
|
2013-02-14 |
2018-04-06 |
Immunocellular Therapeutics Ltd. |
Vacunas contra el cáncer y métodos de vacunación
|
|
US10320290B2
(en)
*
|
2013-08-09 |
2019-06-11 |
Microsemi Corporation |
Voltage regulator with switching and low dropout modes
|
|
DK3277325T3
(da)
|
2015-04-03 |
2021-01-18 |
H Lee Moffitt Cancer Ct & Res |
Kombinationsimmunterapi for cancer
|
|
KR102873947B1
(ko)
|
2015-05-07 |
2025-10-22 |
베이롤 칼리지 오브 메드신 |
수지상 세포 면역요법
|
|
US10801041B2
(en)
|
2015-11-18 |
2020-10-13 |
Orbis Health Solutions, Llc |
T7 alpha viral vector system
|
|
US11020465B2
(en)
|
2016-03-04 |
2021-06-01 |
The Trustees Of Columbia University In The City Of New York |
Development of dual whole cell-based vaccine against pancreatic cancer
|
|
WO2017181163A2
(en)
|
2016-04-16 |
2017-10-19 |
Oncocyte Corporation |
Methods and compositions for detection and diagnosis of breast cancer
|
|
JP2021533759A
(ja)
*
|
2018-08-10 |
2021-12-09 |
ユーティレックス カンパニー リミテッド |
癌抗原特異的ｃｄ８＋ｔ細胞を調製および凍結保存するための方法
|